Endou M, Poli E, Levi R
Department of Pharmacology, Cornell University Medical College, New York, New York.
J Pharmacol Exp Ther. 1994 Apr;269(1):221-9.
Discovered as inhibitory autoreceptors in central histaminergic pathways, histamine H3-receptors may also modulate peripheral cholinergic and central adrenergic function. Recently, H3-receptors were reported to inhibit adrenergic inotropic responses in guinea pig atria, possibly at prejunctional sites. We have assessed whether the H3-mediated modulation of cardiac adrenergic activities results from a reduction in norepinephrine release. We have found that (R) alpha-methylhistamine, the selective histamine H3-receptor agonist, attenuates the inotropic and chronotropic response of isolated guinea pig atria to transmural stimulation of adrenergic nerve endings. This attenuation was associated with a marked reduction in endogenous norepinephrine release. In contrast (R) alpha-methylhistamine did not modify the chronotropic effect of exogenous norepinephrine. The attenuation of adrenergic responses by (R) alpha-methylhistamine was 1) prevented by thioperamide, the selective H3-receptor antagonist; 2) attenuated by pertussis-toxin pretreatment and 3) potentiated by the N-type Ca(++)-channel blocker omega-conotoxin, which also potentiated the sympathetic modulatory effects of adrenergic-alpha 2 and adenosine-A1 receptor agonists. Our findings indicate that prejunctional histamine H3-receptors modulate the depolarization-dependent norepinephrine release from sympathetic nerve endings in the guinea pig myocardium. These receptors are probably coupled to a pertussis-toxin-sensitive Gi/Go protein and probably effect a reduction in Ca++ current. We have previously reported that sympathetic stimulation elicits a frequency-dependent release of cardiac histamine, whereas others had found that adrenergic activity regulates histamine's rapid turnover pool. Accordingly, presynaptic H3-receptors are likely to serve a modulatory role in cardiac adrenergic function.
组胺H3受体最初是在中枢组胺能通路中作为抑制性自身受体被发现的,它也可能调节外周胆碱能功能和中枢肾上腺素能功能。最近,有报道称H3受体可抑制豚鼠心房的肾上腺素能变力反应,可能作用于神经节前部位。我们评估了H3介导的心脏肾上腺素能活动调节是否源于去甲肾上腺素释放的减少。我们发现,选择性组胺H3受体激动剂(R)α-甲基组胺可减弱离体豚鼠心房对肾上腺素能神经末梢跨壁刺激的变力和变时反应。这种减弱与内源性去甲肾上腺素释放的显著减少有关。相比之下,(R)α-甲基组胺并未改变外源性去甲肾上腺素的变时效应。(R)α-甲基组胺对肾上腺素能反应的减弱作用:1)被选择性H3受体拮抗剂硫代哌啶所阻断;2)被百日咳毒素预处理所减弱;3)被N型Ca(++)通道阻滞剂ω-芋螺毒素所增强,后者也增强了肾上腺素能α2和腺苷A1受体激动剂的交感调节作用。我们的研究结果表明,神经节前组胺H3受体可调节豚鼠心肌中交感神经末梢去甲肾上腺素的去极化依赖性释放。这些受体可能与百日咳毒素敏感的Gi/Go蛋白偶联,并可能导致Ca++电流减少。我们之前曾报道,交感神经刺激可引发心脏组胺的频率依赖性释放,而其他人则发现肾上腺素能活动调节组胺的快速周转池。因此,突触前H3受体可能在心脏肾上腺素能功能中发挥调节作用。